Seasonal Affective Disorder Therapeutics Industry Radiant Growth on the Horizon, Anticipated to Achieve US$ 1.1 Billion by 2028-FMI Report

The research states that SSRIs, or selective serotonin reuptake inhibitors, are often prescribed drugs for the treatment of seasonal affective disorder. In the market for seasonal affective disorder treatments industry, there are numerous branded and generic drugs accessible, however Buproban and Citalopram continue to sell at a comparatively greater rate. FMI attributes this supremacy to …